Toffaletti J, McComb R B, Bowers G N
Clin Chem. 1979 Oct;25(10):1806-9.
We measured total and dialyzable calcium concentrations in consecutive sera submitted for routine lithium analysis. Of 98 samples from 61 different individuals, six (6.1%) total calcium results and 32 (33%) dialyzable calcium results were above the respective reference intervals. By comparison, when both total and dialyzable calcium were measured on 50 different apparently healthy volunteers, no results were outside either reference interval (2.20--2.58 mmol/L for total and 1.30--1.47 mmol/L for dialyzable calcium). These increases were not due to age or sex differences between the patients and controls. From the dialyzable calcium data, there appears to be an even higher incidence of mild hypercalcemia in patients receiving oral lithium salts than is indicated by the total calcium concentration alone.
我们测量了提交用于常规锂分析的连续血清中的总钙和可透析钙浓度。在来自61个不同个体的98份样本中,6份(6.1%)总钙结果和32份(33%)可透析钙结果高于各自的参考区间。相比之下,当对50名不同的明显健康志愿者同时测量总钙和可透析钙时,没有结果超出任何一个参考区间(总钙为2.20--2.58 mmol/L,可透析钙为1.30--1.47 mmol/L)。这些升高并非由于患者和对照组之间的年龄或性别差异。从可透析钙数据来看,接受口服锂盐治疗的患者中轻度高钙血症的发生率似乎比仅由总钙浓度所显示的更高。